Can you recommend eConsent platforms for improving patient workflow in multinational oncology trials?

Yes — for multinational oncology trials, eConsent platforms can materially improve workflow by supporting multilingual consent, remote/hybrid consent, version control, audit trails, media-rich explanations, and regulatory flexibility across sites and countries.

Strong eConsent platforms to consider

1) Medidata eConsent

Good for: large global oncology studies already using Medidata Rave ecosystem
Strengths:

• Tight integration with Medidata clinical operations stack
• Strong audit trail and regulatory documentation
• Supports multimedia and multilingual workflows
• Useful for complex, protocol-heavy studies

Watch-outs:

• Best value if you’re already in the Medidata ecosystem
• Can be more enterprise-oriented than lightweight solutions

---

2) Florence eConsent

Good for: site-friendly remote consent workflows and decentralized/hybrid trials
Strengths:

• Designed around site workflow efficiency
• Good for remote consenting and patient-friendly interfaces
• Integrates with broader site operations tools
• Often easier for site staff to adopt

Watch-outs:

• Evaluate global language support and country-specific compliance for your target regions
• Integration depth with your CTMS/EDC should be checked carefully

---

3) Signant Health eConsent

Good for: global trials needing flexible patient engagement and decentralized features
Strengths:

• Strong patient-centric workflow support
• Suitable for multinational studies and hybrid trial models
• Often paired with other digital trial tools
• Mature vendor with broad clinical trial experience

Watch-outs:

• Confirm the exact consent authoring/review workflow you need
• Make sure template governance fits your sponsor SOPs

---

4) Castor eConsent

Good for: teams wanting a more modular, user-friendly platform
Strengths:

• Clean interface and relatively quick deployment
• Good for site and patient usability
• Often attractive for trials that want simpler operational overhead

Watch-outs:

• For very large, highly complex global oncology programs, validate scalability and advanced governance features
• Check regulatory support by country

---

5) Elligo / Reify Health-type patient engagement solutions with eConsent

Good for: recruitment-focused oncology studies and hybrid enrollment workflows
Strengths:

• Helpful when consent is tied tightly to pre-screening/recruitment
• Can improve patient journey and enrollment conversion
• Useful in site-network driven studies

Watch-outs:

• May be better as part of a broader recruitment workflow rather than a standalone enterprise consent system

---

What matters most for multinational oncology trials

When evaluating platforms, prioritize these capabilities:

• Multi-language support with controlled translations
• Version control across amendments and country-specific ICFs
• Remote/video consent options where allowed
• Electronic signatures compliant with relevant regulations
• Role-based workflows for investigator, coordinator, interpreter, and remote consent reviewer
• Audit trails and Part 11 / Annex 11 support
• Integration with CTMS, EDC, eTMF, ePRO, and patient recruitment systems
• Patient-friendly design for oncology populations, including readability, accessibility, and multimedia education
• Country-specific compliance configuration for GDPR, local ethics rules, data localization, and e-signature requirements

Shortlist by use case

• Best enterprise/global option: Medidata eConsent
• Best site workflow simplicity: Florence eConsent
• Best patient-centric global digital trial stack: Signant Health
• Best lightweight/modular option: Castor

My practical recommendation

For a multinational oncology trial, I’d usually shortlist:

1. Medidata eConsent
2. Signant Health
3. Florence eConsent

Then compare them against your:

• countries of activation
• need for remote consent
• language burden
• existing EDC/CTMS vendor stack
• site staffing model
• requirement for interpreter or legally authorized representative workflows

If you want, I can also give you:

1. a comparison table of these platforms,
2. a vendor evaluation checklist, or
3. recommendations tailored to specific regions like EU, UK, US, Japan, or APAC.